The Zerigo System is the first and only connected phototherapy system that uses an app on the patient’s own smartphone (iOS or Android) to manage the dose, frequency, and duration of targeted narrowband UVB (NB-UVB) light therapy for the treatment of chronic skin diseases such as psoriasis, vitiligo, and eczema. The System helps to ensure that patients receive the proper doses recommended by the American Academy of Dermatology and Vitiligo Working Group’s published treatment protocols. The treatment regimen is prescribed by the patient’s physician but monitored and controlled by the Zerigo System, enabling patients to administer treatment with clinical precision and achieve clinical efficacy in the convenience of their homes. The cloud-based system monitors dosing, adherence, compliance, patient progress and satisfaction.

The Zerigo smartphone app syncs to a patented, lightweight, handheld device which guides patients through delivering targeted narrowband UVB phototherapy treatments for their specific skin conditions. All treatment records, including photographs and patient-reported outcomes, are available to both the patient and the physician and can be used for evaluation during follow-up visits. Zerigo CarePartners, trained patient support personnel, act as the first line of support for patients – coaching them on the use of the system and encouraging treatment adherence – greatly reducing the burden of these functions on the physician’s practice.